Repeatability of parametric methods for [18F]florbetapir imaging in Alzheimer’s disease and healthy controls: A test–retest study

Quantification of [18F]florbetapir: A test–retest tracer kinetic modelling study

(2018) Sandeep SV Golla et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Assessing Amyloid Pathology in Cognitively Normal Subjects using [18F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods

(2018) Lyduine Collij et al.   JOURNAL OF NUCLEAR MEDICINE

Validation of the Semiquantitative Static SUVR Method for 18 F-AV45 PET by Pharmacokinetic Modeling with an Arterial Input Function

(2017) Julie Ottoy et al.   JOURNAL OF NUCLEAR MEDICINE

Forward to the Past: The Case for Quantitative PET Imaging

(2017) Adriaan A. Lammertsma   JOURNAL OF NUCLEAR MEDICINE

Clinicopathologic and11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum

(2015) Melissa E. Murray et al.   BRAIN

Cerebral perfusion and glucose metabolism in Alzheimer’s disease and frontotemporal dementia: two sides of the same coin?

(2015) Sander C. J. Verfaillie et al.   EUROPEAN RADIOLOGY

Prevalence of Amyloid PET Positivity in Dementia Syndromes

(2015) Rik Ossenkoppele et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Measurement of Longitudinal  -Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios

(2015) S. M. Landau et al.   JOURNAL OF NUCLEAR MEDICINE

Parametric imaging and quantitative analysis of the PET amyloid ligand [ 18 F]flutemetamol

(2015) Kerstin Heurling et al.   NEUROIMAGE

Comparison of Simplified Parametric Methods for Visual Interpretation of 11C-Pittsburgh Compound-B PET Images

(2014) M. D. Zwan et al.   JOURNAL OF NUCLEAR MEDICINE

Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease

(2014) Niklas Mattsson et al.   Annals of Clinical and Translational Neurology

Neuropathologic Heterogeneity Does Not Impair Florbetapir-Positron Emission Tomography Postmortem Correlates

(2013) Brittany N. Dugger et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Longitudinal Amyloid Imaging Using 11C-PiB: Methodologic Considerations

(2013) B. N. M. van Berckel et al.   JOURNAL OF NUCLEAR MEDICINE

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

Brain Amyloid Imaging — FDA Approval of Florbetapir F18 Injection

(2012) Lucie Yang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

(2012) Randall J. Bateman et al.   NEW ENGLAND JOURNAL OF MEDICINE

In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)

(2010) D. F. Wong et al.   JOURNAL OF NUCLEAR MEDICINE

Test-retest variability of quantitative [11C]PIB studies in Alzheimer’s disease

(2009) Nelleke Tolboom et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING